Insights on PBLA

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, -1.58M → -1.63M (in $), with an average decrease of 3.1% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -6.47M → -7.12M (in $), with an average decrease of 10.0% per quarter

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 67.0% return, outperforming this stock by 166.8%

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 245.2% return, outperforming this stock by 345.2%

Highlights

Market Capitalization
2.2M
Book Value
- $9.81
Earnings Per Share (EPS)
-316.52
PEG Ratio
0.0
Wall Street Target Price
500.0
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-191.05%
Return On Equity TTM
-798.16%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
Diluted Eps TTM
-316.52
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-6.87
EPS Estimate Next Year
-4.7
EPS Estimate Current Quarter
-1.62
EPS Estimate Next Quarter
-1.3

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Moderna, Inc.
Moderna, Inc.
49.27%
114.37%
32.42%
-7.2%
673.49%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
10.37%
23.42%
35.19%
98.86%
219.88%
Novo Nordisk A/s
Novo Nordisk A/s
7.22%
30.97%
70.25%
245.19%
467.54%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
15.33%
30.49%
40.47%
120.42%
164.5%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-6.6
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
28.99
28.99
1.46
44.13
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
46.75
46.75
2.36
3.5
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
29.23
29.23
0.53
17.14
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Moderna, Inc.
Moderna, Inc.
Buy
$63.9B
673.49%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$108.0B
219.88%
28.99
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$605.7B
467.54%
46.75
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$116.3B
164.5%
29.23
39.46%

FAQs